#DiabetesResearch
LightNews LightNews
dzg-forschen.bsky.social
At #FallingWalls, Stefan Bornstein (DZD), Heiko Lickert (Helmholtz Munich) and Stefan Irion (GC Therapeutics) discuss how beta-cell replacement and regeneration could transform the treatment of type 1 diabetes.
➡️https://t1p.de/vuze8
#T1D #DiabetesResearch #DZD
November 4, 2026 at 7:36 AM
isletbiologylab.bsky.social
Thank you so much to #EFSD and #Lilly for the incredible support throughout this grant!

It was an honor to be part of the programme and to have our work featured in this research portrait.

#DiabetesResearch #Type1Diabetes #BetaCells #Science #WomenInSTEM
easdnews.bsky.social European Association for the Study of Diabetes @easdnews.bsky.social · 3d
🧠Meet Dr. Laura Marroquí, #EFSD & Lilly 🇪🇺 #Diabetes Research Programme award recipient. Her project targets TYK2 signalling to protect beta cells from inflammatory damage. In mice, a peptide inhibitor delayed #diabetes onset in females & reduced incidence in males.

📄 Publication coming soon.
EFSD social media graphic titled “Recipient Research Portrait…” in bold navy text on a blue, teal and lime-green geometric background, with light-blue, white and green concentric rings in the upper right. A circular photo with a navy border shows Dr Laura Marroquí, a smiling woman with short, dark, wavy hair and drop earrings, wearing a black top and standing in front of a light stone wall. Text below the title reads “Doctor Laura Marroquí, Miguel Hernández University of Elche, Spain”. A light-blue footer band shows the EFSD logo and the text “European Foundation for the Study of Diabetes”. EFSD social media graphic with a light-blue background and navy and cyan ring shapes at the right edge. A teal box at the top contains the headline “Targeting IFNα pathway with protein-protein interaction inhibitors as a therapeutic strategy for type 1 diabetes”. Below it, a lime-green box reads: “Laura Marroquí explores an innovative therapeutic strategy using a peptide designed to inhibit the IFNα signalling pathway, aiming to protect beta cells from inflammatory damage and delay the development of type 1 diabetes.” The EFSD logo and the text “European Foundation for the Study of Diabetes” appear at the bottom left. EFSD social media graphic with a light-blue background and large cyan and navy ring shapes behind the text boxes. A lime-green label at the top left reads “Supported by the”. A teal box below it reads “EFSD and Lilly European Diabetes Research Programme”. A large navy box at the bottom carries the call to action in bold white text, “Apply for research grants and fellowships”, followed by the web address europeandiabetesfoundation.org.
November 4, 2026 at 10:56 AM
faseborg.bsky.social
🩺 A study in FASEB BioAdvances identified two blood-based candidate biomarkers, SLC7A5 and SLC2A14, associated with diabetic kidney disease. The findings offer new clues about disease-related pathways, but larger studies are needed to confirm their diagnostic value. buff.ly/dUt6VaF #DiabetesResearch
November 3, 2026 at 5:01 PM
brian98er.bsky.social
New Research Topic in Frontiers in Endocrinology:

Pancreatic islet heterogeneity & plasticity in diabetes.

We welcome work on cell states, metabolism, and single-cell/spatial omics.

📅 Aug 31, 2027
🔗 www.frontiersin.org/research-top...

#DiabetesResearch
Frontiers | Cellular Heterogeneity and Plasticity in Pancreatic Islets: Implications for Diabetes
The pancreatic islet has long been described as a set of well-defined endocrine cell types – β, α, δ, ε, and PP cells – each with a fixed identity and a sing...
www.frontiersin.org
November 5, 2026 at 4:17 AM
jaisloweddown.bsky.social
Burger King Employee Finally Explains Why She Painted Her FaceBlack! shorturl.at/CdUUW

#Type2Diabetes #DiabetesResearch #DiabetesReversal #HealthNews #MedicalBreakthrough #HealthStudy #TheLancet #DiabetesAwareness #HealthyLifestyle #WeightLossJourney #LowCalorieDiet #StrengthTraining
November 3, 2026 at 3:42 PM
diabetologiajnl.bsky.social
Prediabetes is dynamic and heterogeneous. Combining glycaemic subtypes with insulin secretion and sensitivity identifies those most likely to progress to #diabetes or regress to normoglycaemia #prediabetes #diabetesresearch #T2D link.springer.com/article/10.1... 🔓
October 29, 2026 at 12:03 PM
thriveabetes.bsky.social
As part of their project for SciFest Nationals, they're creating a video that puts the voices and experiences of people living with diabetes at the heart of their work.

🎥 Would you share your experience?
They'd love to hear about:

#Thriveabetes #BioPancrea #SciFest #DiabetesResearch
BioPancrea | Biotechnology Startup
BioPancrea is developing a research-stage, implantable artificial-pancreas concept combining beta-like cells, hydrogel and a vascular stent.
buff.ly
October 30, 2026 at 8:15 PM
robertlufkinmd.bsky.social
Full breakdown coming on the Health Longevity Secrets podcast www.youtube.com/@RobertLufkinMD

NEJM: doi.org/10.1056/NEJM...

#MetabolicHealth #DiabetesResearch #HealthLongevitySecrets (5/5)
October 25, 2026 at 6:46 PM
drhowardsmith.bsky.social
Olive Oil Reduces Blood Sugar Surges. If human studies confirm these animal does, hanging the order in which you consume foods could become another strategy for managing blood sugar. #BloodSugar #DiabetesResearch #OliveOil #Nutrition #HealthNews
www.instagram.com/p/De4y7mcuN6a/
October 24, 2026 at 6:45 PM
cnag-eu.bsky.social
1️⃣ 𝘈 𝘩𝘪𝘨𝘩-𝘳𝘦𝘴𝘰𝘭𝘶𝘵𝘪𝘰𝘯 𝘤𝘦𝘭𝘭𝘶𝘭𝘢𝘳 𝘮𝘢𝘱

▫️ Researchers analysed +4 million cells and cell nuclei from pancreatic tissue samples spanning fetal development to adulthood, including #Type2diabetes
▫️ The study combined 10 complementary genomic techniques

#Multiomics #Type2Diabetes #DiabetesResearch #Genomics
October 23, 2026 at 11:51 AM
biomedicines.bsky.social
🔬 Which markers best predict blood glucose outcomes after COVID-19?
This study highlights initial blood glucose, HOMA-IR & hs-CRP as significant predictors of elevated glycemia.
#PostCOVID #DiabetesResearch
www.mdpi.com/2227-9059/12...
October 22, 2026 at 12:21 AM
nabamart.bsky.social
United States have discovered that the Miro1 protein, a component of mitochondrial membranes, plays a pivotal role in the development of insulin resistance in patients with type 2 diabetes.

#InsulinResistance #DiabetesResearch #ProteinDiscovery #MedicalScience #HealthNews
October 20, 2026 at 4:29 PM
queerguide.bsky.social
Gender-affirming care changed my life. That’s why I’m running the NYC Marathon. #diabetesResearch #familySupport
Gender-affirming care changed my life. That’s why I’m running the NYC Marathon.
In 2009, my dad ran the New York City Marathon because he felt helpless. I had just been diagnosed with Type 1 diabetes. I was 12 years old, and suddenly our lives revolved around sugar checks, insulin, carbohydrates and a condition that wasn’t going anywhere. My dad couldn’t take diabetes away from
queer.guide
October 22, 2026 at 4:17 AM
avicennaresearch.bsky.social
How can researchers bring continuous glucose data into their studies?
Avicenna’s Buzud integration supports collecting continuous glucose monitoring (CGM) readings alongside surveys and other research data.
Learn how it works: forum.avicennaresearch.com/t/buzud/1617

#DigitalHealth #DiabetesResearch
October 19, 2026 at 10:34 AM
diabetologiajnl.bsky.social
Genetic background can influence diabetes penetrance and beta cell ageing in a genetic mouse model of diabetes #Diabetes #BetaCells #DiabetesResearch link.springer.com/article/10.1... 🔓 @chalab2022.bsky.social
Genetic background modulates MafAS64F-mediated islet ageing in male mice - Diabetologia
Aims/hypothesis In monogenic diabetes, there is increasing recognition that common polygenic factors can modulate diabetes penetrance beyond the causative mutation(s). A naturally occurring mutation i...
link.springer.com
October 19, 2026 at 7:13 AM
jcst2d.bsky.social
New research strengthens the case for CGM in type 2 diabetes without insulin. The CONNECT trial found improved A1c, Time in Range, and patient satisfaction.

jcst2d.com/index.php/ar...

#Type2Diabetes #CGM #DiabetesResearch
CONNECT trial summary comparing continuous glucose monitoring (CGM) with routine care in 283 adults with type 2 diabetes not using insulin. Over 26 weeks, the CGM group (145 participants) reduced A1c from 8.8% to 7.2%, compared with 8.7% to 8.0% in the routine care group (138 participants). Time in Range (70–180 mg/dL) increased from 29% to 62% with CGM, compared with 31% to 41% with routine care. The adjusted difference represented approximately five additional hours per day in range. An A1c reduction of at least 0.5 percentage points was achieved by 82% of CGM users versus 56% of routine care participants. CGM users also reported greater satisfaction with glucose monitoring and less diabetes-related distress.
October 19, 2026 at 12:59 AM
diabetologiajnl.bsky.social
CGM to track beta cell function in preclinical T1D: a novel digital biomarker to predict disease progression #T1D #CGM #DiabetesResearch link.springer.com/article/10.1... 🔓️
October 16, 2026 at 9:01 AM
purescience.news
Weight loss medications alter how the brain and kidneys manage body fluids #Science #HealthandMedicine #weightloss #liraglutide #diabetesresearch #kidneyfunction #hormones
Weight loss medications alter how the brain and kidneys manage body fluids
Medications like liraglutide help treat diabetes and obesity, but they also influence how the body handles water and sodium. A new study shows that these drugs directly lower levels of a key...
purescience.news
October 17, 2026 at 4:38 AM
diabetologiajnl.bsky.social
New study: visceral fat #endocannabinoid overproduction is driven by #InsulinResistance & tissue dysfunction, not obesity alone, in mice & humans. #Type2Diabetes #AdiposeTissue #DiabetesResearch link.springer.com/article/10.1...
October 15, 2026 at 6:01 AM
diabetologiajnl.bsky.social
BAF60A preserves beta cell identity and insulin secretion via ISL1. BAF60A loss promotes dedifferentiation, while overexpression improves beta cell function #Diabetes #BetaCells #Epigenetics #DiabetesResearch link.springer.com/article/10.1...
October 14, 2026 at 11:01 AM
lott54.bsky.social
New diabetes pill orforglipron achieves uniform weight loss for women of all ages

#Orforglipron #DiabetesResearch #WeightLoss #DiabetesTreatment #Type2Diabetes #WeightLossResearch #GLP1 #WomensHealth

linkbiite.com/new-diabetes...
New diabetes pill orforglipron achieves uniform weight loss for women of all ages -
New analyses to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) show that
linkbiite.com
October 15, 2026 at 6:08 AM
purescience.news
Scientists may have found why diabetic wounds refuse to heal #Science #HealthandMedicine #MedicalTechnology #diabetesresearch #woundhealing #immunotherapy #chronicwounds #tissuerepair

https://purescience.news/read?id=234756091873853440
Scientists may have found why diabetic wounds refuse to heal
Chronic diabetic wounds may fail to heal because immune cells remain locked in damaging inflammatory states instead of transitioning toward tissue repair. Researchers are exploring treatments that reprogram these immune responses, raising hopes for more targeted and effective therapies for diabetic ulcers.
purescience.news
October 11, 2026 at 1:44 AM
diabresearch-dzd.bsky.social
🔬 DZD at EASD 2026:A short photo review
Exciting research, inspiring scientific sessions, prestigious awards and many valuable conversations at the DZD booth. Thank you to everyone who visited us and helped make #EASD2026 such a special event!
📸 A short photo review
#DZD #DiabetesResearch
October 6, 2026 at 6:45 AM
aiinmeditech.bsky.social
What makes EASD influential among diabetes experts?

Our latest KOL study examines scientific credibility, emerging treatment evidence, clinical influence, and future opportunities.

Explore the findings:
www.sperresearch.com/Case-Studies...

#EASD #DiabetesResearch #KOLInsights #Healthcare
EASD KOL Perception Study: Key Diabetes Insights
Explore how 25 diabetes KOLs perceive EASD’s scientific value, clinical influence, content relevance and future opportunities.
www.sperresearch.com
October 6, 2026 at 6:38 AM